{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:41:31Z","timestamp":1787499691059,"version":"build-2736575974"},"reference-count":51,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chang Gung Memorial Hospital","award":["CRRPG2H0052"],"award-info":[{"award-number":["CRRPG2H0052"]}]},{"name":"Chang Gung Memorial Hospital","award":["CMRPG2H0383"],"award-info":[{"award-number":["CMRPG2H0383"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Elevated serum ferritin and uric acid levels are common in patients with fatty liver disease. This study assessed the association between serum ferritin and uric acid levels and liver fibrosis in subjects with lean metabolic dysfunction-associated fatty liver disease (MAFLD). This cross-sectional study used data from a community screening examination for metabolic syndrome from December 2018 to September 2019 at Keelung Chang Gung Memorial Hospital. Subjects with lean MAFLD were defined as those with a body mass index (BMI) &lt; 23 kg\/m2 and hepatic steatosis according to the MAFLD criteria. A total of 182 lean subjects were included and were divided into lean MAFLD and lean healthy groups. Serum ferritin and uric acid concentrations were positively correlated with liver fibrosis, regardless of whether FIB-4, APRI, or NFS were used as references. Univariate logistic regression analysis showed that age and uric acid were associated with advanced liver fibrosis. After adjusting for potential confounders, only uric acid level was statistically significant in predicting the advanced liver fibrosis (OR = 6.907 (1.111\u201342.94), p = 0.038) in the lean MAFLD group. We found that an elevated serum uric acid level is an independent factor associated with advanced liver fibrosis in lean MAFLD subjects by noninvasive fibrosis scores.<\/jats:p>","DOI":"10.3390\/jpm12122009","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T02:56:26Z","timestamp":1670208986000},"page":"2009","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum Uric Acid but Not Ferritin Level Is Associated with Hepatic Fibrosis in Lean Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease: A Community-Based Study"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6605-7120","authenticated-orcid":false,"given":"Cheng-Han","family":"Xie","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital and University, Keelung 204, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8805-2275","authenticated-orcid":false,"given":"Li-Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital and University, Keelung 204, Taiwan"},{"name":"Community Medicine Research Center, Chang-Gung Memorial Hospital and University, Keelung 204, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Lang","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital and University, Keelung 204, Taiwan"},{"name":"Community Medicine Research Center, Chang-Gung Memorial Hospital and University, Keelung 204, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chih","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital and University, Keelung 204, Taiwan"},{"name":"Community Medicine Research Center, Chang-Gung Memorial Hospital and University, Keelung 204, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hung","family":"Chien","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital and University, Keelung 204, Taiwan"},{"name":"Community Medicine Research Center, Chang-Gung Memorial Hospital and University, Keelung 204, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jgh.12251","article-title":"Non-alcoholic fatty liver disease: Factors associated with its presence and onset: Risk of non-alcoholic fatty liver disease","volume":"28","author":"Miyake","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: A feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.02.009","article-title":"Epidemiology and Natural History of NAFLD and NASH","volume":"11","author":"Ong","year":"2007","journal-title":"Clin. Liver Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease","volume":"363","author":"Targher","year":"2010","journal-title":"New Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MCG.0000000000001270","article-title":"The Prevalence of Lean\/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"54","author":"Shi","year":"2020","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/apt.14401","article-title":"Systematic review with meta-analysis: The significance of histological disease severity in lean patients with nonalcoholic fatty liver disease","volume":"47","author":"Sookoian","year":"2018","journal-title":"Aliment Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lombardi, R., Pisano, G., and Fargion, S. (2016). Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD. IJMS, 17.","DOI":"10.3390\/ijms17040548"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2011.04788.x","article-title":"Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease: Uric acid and NASH","volume":"34","author":"Petta","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"E104","DOI":"10.1111\/hepr.12734","article-title":"Relationship of serum uric acid level with non-alcoholic fatty liver disease and its inflammation progression in non-obese adults: Serum uric acid level","volume":"47","author":"Liu","year":"2017","journal-title":"Hepatol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/hep.23717","article-title":"Association between serum uric acid level and chronic liver disease in the United States","volume":"52","author":"Afzali","year":"2010","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cgh.2013.11.035","article-title":"Serum Ferritin Levels Lack Diagnostic Accuracy for Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease","volume":"12","author":"Angulo","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/liv.14096","article-title":"Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease","volume":"39","author":"Buzzetti","year":"2019","journal-title":"Liver Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.20023","article-title":"Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver","volume":"39","author":"Bugianesi","year":"2004","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Yen, P.-C., Chou, Y.-T., Li, C.-H., Sun, Z.-J., Wu, C.-H., Chang, Y.-F., Lu, F.-H., Yang, Y.-C., Chang, C.-J., and Wu, J.-S. (2022). Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It. JCM, 11.","DOI":"10.3390\/jcm11051445"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"821689","DOI":"10.3389\/fendo.2022.821689","article-title":"A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"(2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation, 106, 3143.","DOI":"10.1161\/circ.106.25.3143"},{"key":"ref_24","first-page":"616271","article-title":"Epidemiologic Behavior and Estimation of an Optimal Cut-Off Point for Homeostasis Model Assessment-2 Insulin Resistance: A Report from a Venezuelan Population","volume":"2014","author":"Rojas","year":"2014","journal-title":"Int. Sch. Res. Not."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00042","DOI":"10.14309\/ctg.0000000000000042","article-title":"Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup","volume":"10","author":"Hsu","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.292.6512.13","article-title":"Ultrasound scanning in the detection of hepatic fibrosis and steatosis","volume":"292","author":"Saverymuttu","year":"1986","journal-title":"BMJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: A multicenter large retrospective study","volume":"47","author":"Eguchi","year":"2012","journal-title":"J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diabetes.47.5.699","article-title":"The metabolically obese, normal-weight individual revisited","volume":"47","author":"Ruderman","year":"1998","journal-title":"Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"086","DOI":"10.1055\/s-0038-1677517","article-title":"NASH in Lean Individuals","volume":"39","author":"Younes","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00004836-200609000-00016","article-title":"Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese Adults","volume":"40","author":"Chen","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/nyas.12016","article-title":"Nonalcoholic fatty liver disease: An emerging threat to obese and diabetic individuals","volume":"1281","author":"Masuoka","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"Dowman","year":"2010","journal-title":"QJM"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12072-018-9892-8","article-title":"Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population","volume":"13","author":"Jung","year":"2019","journal-title":"Hepatol Int"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.clinbiochem.2015.12.010","article-title":"High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"49","author":"Zhou","year":"2016","journal-title":"Clin. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12944-017-0613-4","article-title":"Association of serum ferritin with non-alcoholic fatty liver disease: A meta-analysis","volume":"16","author":"Du","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/liv.13329","article-title":"Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis","volume":"37","author":"Wijarnpreecha","year":"2017","journal-title":"Liver Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/dmrr.2506","article-title":"Association of iron indices and type 2 diabetes: A meta-analysis of observational studies","volume":"30","author":"Orban","year":"2014","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Abril-Ulloa, V., Flores-Mateo, G., Sol\u00e0-Alberich, R., Manuel-y-Keenoy, B., and Arija, V. (2014). Ferritin levels and risk of metabolic syndrome: Meta-analysis of observational studies. BMC Public Health, 14.","DOI":"10.1186\/1471-2458-14-483"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1478-3231.2011.02488.x","article-title":"Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients: Ferritin and NASH","volume":"31","author":"Manousou","year":"2011","journal-title":"Liver Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1128\/MCB.20.16.5818-5827.2000","article-title":"Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress","volume":"20","author":"Tsuji","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/hep.22716","article-title":"Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells","volume":"49","author":"Ruddell","year":"2009","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","first-page":"5","article-title":"Uric acid induces liver fibrosis through activation of inflammatory mediators and proliferating hepatic stellate cell in mice","volume":"75","author":"Sari","year":"2020","journal-title":"Med. J. Malays."},{"key":"ref_47","first-page":"360","article-title":"Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice","volume":"133","author":"Cook","year":"2003","journal-title":"Swiss Med. Wkly."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Khosla","year":"2005","journal-title":"Kidney Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jhep.2015.01.019","article-title":"Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds","volume":"62","author":"Xu","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1210\/jc.2015-2527","article-title":"Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies","volume":"100","author":"Yuan","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/BOR.0b013e32835d951e","article-title":"Metabolic syndrome, diabetes, and hyperuricemia","volume":"25","author":"Li","year":"2013","journal-title":"Curr. Opin. Rheumatol."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/12\/2009\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:33:31Z","timestamp":1760146411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/12\/2009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,3]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["jpm12122009"],"URL":"https:\/\/doi.org\/10.3390\/jpm12122009","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,3]]}}}